COMMUNIQUÉS West-GlobeNewswire

MAIA Biotechnology’s Phase 3 Momentum Demonstrates Potential Breakthrough Anticancer Opportunity in $50 Billion Immunotherapy Market
24/02/2026
Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysis FDA Fast Track designation offers clear pathway for ateganosine as third-line therapy [...]
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
24/02/2026
Results in a population of 278 patients affirm statistically significant mortality reductions Benefits observed across severity groups and in subjects with serious comorbidities Company files provisional patent [...]
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
24/02/2026
NEEDHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
24/02/2026
Center to Create Local Jobs and Strengthen U.S. Healthcare Supply Resilience SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing [...]
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market
24/02/2026
150-Patient, Triple-Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission for Drug-Free Insomnia Treatment Builds on Prior Peer-Reviewed Clinical [...]
Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
24/02/2026
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery compared to placebo [...]
Respiree Strengthens Series A Syndicate to Advance Next-Generation Cardiorespiratory Care
24/02/2026
HOUSTON and SINGAPORE, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Respiree , a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, today announced [...]
24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production
24/02/2026
March issue of National Geographic explores how engineered silkworms are spinning one of nature’s most powerful materials at scale DENVER, Feb. 24, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media [...]
Human Continuum Appoints Dr. Michael Milligan, MD, MBA, as its Chief Medical Officer to Oversee Innovative Applications for Next-Generation Extracellular Vesicle Therapeutics
24/02/2026
New York, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”) , a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced that it has [...]
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons
24/02/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed an exclusive US distribution agreement with RMR Ortho to add the A’TOMIC™ Nitinol Fixation System to the Smith+Nephew [...]
Professional Golfer Max Homa Joins Arcutis’ Free to Be Me Campaign, Urging Individuals with Seborrheic Dermatitis to Tee Up a Conversation with Their Healthcare Provider About Long-Term Treatments
24/02/2026
Max Homa shares his journey with seborrheic dermatitis to encourage others to take control of their symptoms ZORYVE ® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to [...]
Centre for Neuro Skills Physician-Researcher Dr. Brent Masel to Receive NABIS Legends Award for Lifetime of Contributions to Traumatic Brain Injury Care
24/02/2026
North American Brain Injury Society honors the pioneering neurorehabilitation researcher and clinician at the NABIS 18th Annual Conference on Brain Injury, March 11–13, 2026, Hilton Arlington National Landing, Arlington [...]
Dentsply Sirona and Burkhart Dental Supply Announce Expanded Distribution Partnership to Include Dental Technology Equipment
24/02/2026
As of April 1, Burkhart Dental Supply will represent Dentsply Sirona’s full portfolio of dental technology solutions in addition to preventive and restorative solutions it already distributes. The expanded partnership [...]
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
24/02/2026
CORAL GABLES, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and [...]
The Uniqueness of Dr Allen’s Devices for Prostate, Kidneys and Low Back Pain Treatment Unveiled Worldwide
24/02/2026
Oxford, UK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Topical summits in Dubai, Berlin, Nanjing, Basel, Lisbon, London and other cities discussed the uniqueness of Dr Allen's Devices , a new revolutionary medical technology [...]
TAP Sleep Care Groundbreaking Dual Therapy: Mouth Shield + TAP Improves Oral, Cardiac, and Cognitive Health in OSA
24/02/2026
DALLAS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- TAP Sleep Care , powered by Airway Management, today highlights groundbreaking clinical research on the benefits of dual therapy using the patented Mouth Shield with TAP devices [...]
CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals
24/02/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 24, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today notes the announcement issued this morning by Sarborg Limited regarding the [...]
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer
24/02/2026
- Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - - First-in-kind technology delivers intra-tumoral alpha-emitting radiotherapeutics, reflects strength [...]
EmblemHealth and Mae Health Announce Partnership to Give Members Access to Pregnancy and Postpartum Digital Health Support and Community-Based Doulas
24/02/2026
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- EmblemHealth has launched a new maternal health partnership with digital health platform Mae Health (“Mae”) to expand access to high-quality, culturally-responsive pregnancy [...]

Pages